335 related articles for article (PubMed ID: 16319340)
21. The association of pneumococcal vaccination with hospitalization and mortality in hemodialysis patients.
Gilbertson DT; Guo H; Arneson TJ; Collins AJ
Nephrol Dial Transplant; 2011 Sep; 26(9):2934-9. PubMed ID: 21317410
[TBL] [Abstract][Full Text] [Related]
22. The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program.
Tsai YH; Hsieh MJ; Chang CJ; Wen YW; Hu HC; Chao YN; Huang YC; Yang CT; Huang CC
Vaccine; 2015 Jun; 33(25):2897-902. PubMed ID: 25936662
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive disease and hospital-treated pneumonia among people aged ≥65 years: a retrospective case-control study.
Leventer-Roberts M; Feldman BS; Brufman I; Cohen-Stavi CJ; Hoshen M; Balicer RD
Clin Infect Dis; 2015 May; 60(10):1472-80. PubMed ID: 25669354
[TBL] [Abstract][Full Text] [Related]
24. Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016.
Vila-Corcoles A; Hospital I; Ochoa-Gondar O; Satue E; de Diego C; Vila-Rovira A; Gómez-Bertomeu F; Raga X; Aragón M
Vaccine; 2020 Jan; 38(5):1170-1180. PubMed ID: 31759735
[TBL] [Abstract][Full Text] [Related]
25. The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study.
Wiemken TL; Carrico RM; Klein SL; Jonsson CB; Peyrani P; Kelley RR; Aliberti S; Blasi F; Fernandez-Gonzalez R; Lopardo G; Ramirez JA;
Vaccine; 2014 Apr; 32(19):2198-203. PubMed ID: 24613522
[TBL] [Abstract][Full Text] [Related]
26. Pneumococcal vaccination in the prevention of community-acquired pneumonia: an optimistic view of cost-effectiveness.
Fedson DS
Semin Respir Infect; 1993 Dec; 8(4):285-93. PubMed ID: 7938925
[TBL] [Abstract][Full Text] [Related]
27. Evaluating clinical effectiveness of pneumococcal vaccination in preventing stroke: the CAPAMIS Study, 3-year follow-up.
Vila-Corcoles A; Ochoa-Gondar O; Rodriguez-Blanco T; de Diego-Cabanes C; Satue-Gracia E; Vila-Rovira A; Torrente Fraga C;
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1577-84. PubMed ID: 24656243
[TBL] [Abstract][Full Text] [Related]
28. [Prevention of community-acquired pneumonia in adults].
Barros M M; Cartagena S C; Bavestrello F L
Rev Chilena Infectol; 2005; 22 Suppl 1():s67-74. PubMed ID: 16163421
[TBL] [Abstract][Full Text] [Related]
29. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia.
Fisman DN; Abrutyn E; Spaude KA; Kim A; Kirchner C; Daley J
Clin Infect Dis; 2006 Apr; 42(8):1093-101. PubMed ID: 16575726
[TBL] [Abstract][Full Text] [Related]
30. Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study.
Hung CC; Chen MY; Hsieh SM; Hsiao CF; Sheng WH; Chang SC
Vaccine; 2004 May; 22(15-16):2006-12. PubMed ID: 15121313
[TBL] [Abstract][Full Text] [Related]
31. Influence of prior pneumococcal and influenza vaccination on outcomes of older adults with community-acquired pneumonia.
Manzur A; Izquierdo C; Ruiz L; Sousa D; Bayas JM; Celorrio JM; Varona W; Nebot M; Salleras L; Domínguez A; Carratalà J;
J Am Geriatr Soc; 2011 Sep; 59(9):1711-6. PubMed ID: 21806565
[TBL] [Abstract][Full Text] [Related]
32. Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy.
Boccalini S; Azzari C; Resti M; Valleriani C; Cortimiglia M; Tiscione E; Bechini A; Bonanni P
Vaccine; 2011 Nov; 29(51):9521-8. PubMed ID: 22008820
[TBL] [Abstract][Full Text] [Related]
33. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.
Bonten MJ; Huijts SM; Bolkenbaas M; Webber C; Patterson S; Gault S; van Werkhoven CH; van Deursen AM; Sanders EA; Verheij TJ; Patton M; McDonough A; Moradoghli-Haftvani A; Smith H; Mellelieu T; Pride MW; Crowther G; Schmoele-Thoma B; Scott DA; Jansen KU; Lobatto R; Oosterman B; Visser N; Caspers E; Smorenburg A; Emini EA; Gruber WC; Grobbee DE
N Engl J Med; 2015 Mar; 372(12):1114-25. PubMed ID: 25785969
[TBL] [Abstract][Full Text] [Related]
34. Preventive effects of pneumococcal and influenza vaccines on community-acquired pneumonia in older individuals in Japan: a case-control study.
Suzuki K; Kondo K; Washio M; Nakashima K; Kan S; Imai S; Yoshimura K; Ota C; Ohfuji S; Fukushima W; Hirota Y
Hum Vaccin Immunother; 2019; 15(9):2171-2177. PubMed ID: 30785356
[TBL] [Abstract][Full Text] [Related]
35. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group.
Ortqvist A; Hedlund J; Burman LA; Elbel E; Höfer M; Leinonen M; Lindblad I; Sundelöf B; Kalin M
Lancet; 1998 Feb; 351(9100):399-403. PubMed ID: 9482293
[TBL] [Abstract][Full Text] [Related]
36. 23-valent pneumococcal polysaccharide vaccine improves survival in dialysis patients by preventing cardiac events.
Ihara H; Kikuchi K; Taniguchi H; Fujita S; Tsuruta Y; Kato M; Mitsuishi Y; Tajima K; Kodama Y; Takahashi F; Takahashi K; Azuma N
Vaccine; 2019 Oct; 37(43):6447-6453. PubMed ID: 31526624
[TBL] [Abstract][Full Text] [Related]
37. Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: A meta-analysis.
Zhang YY; Tang XF; Du CH; Wang BB; Bi ZW; Dong BR
Hum Vaccin Immunother; 2016 Dec; 12(12):3056-3064. PubMed ID: 27629584
[TBL] [Abstract][Full Text] [Related]
38. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study.
Christenson B; Lundbergh P; Hedlund J; Ortqvist A
Lancet; 2001 Mar; 357(9261):1008-11. PubMed ID: 11293594
[TBL] [Abstract][Full Text] [Related]
39. Association between pneumococcal vaccination and cardiovascular outcomes: a systematic review and meta-analysis of cohort studies.
Vlachopoulos CV; Terentes-Printzios DG; Aznaouridis KA; Pietri PG; Stefanadis CI
Eur J Prev Cardiol; 2015 Sep; 22(9):1185-99. PubMed ID: 25252595
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly - Selection of controls in a case-control study.
Kondo K; Suzuki K; Washio M; Ohfuji S; Fukushima W; Maeda A; Hirota Y;
Vaccine; 2017 Aug; 35(36):4806-4810. PubMed ID: 28818473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
